Serum metabolomic profiling of prostate cancer risk in the prostate lung colorectal and ovarian cancer screening trial

摘要

Background: Two recent metabolomic analyses found serum lipid, energy, and other metabolites related to aggressive prostate cancer risk up to 20 years prior to diagnosis.